NeueHealth Inc. (NEUE)
NeueHealth Statistics
Share Statistics
NeueHealth has 8.65M shares outstanding. The number of shares has increased by 5.23% in one year.
| Shares Outstanding | 8.65M |
| Shares Change (YoY) | 5.23% |
| Shares Change (QoQ) | 4.45% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 2.82M |
| Failed to Deliver (FTD) Shares | 242 |
| FTD / Avg. Volume | 0.94% |
Short Selling Information
The latest short interest is 29.26K, so 0.34% of the outstanding shares have been sold short.
| Short Interest | 29.26K |
| Short % of Shares Out | 0.34% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.45 and the forward PE ratio is -0.53. NeueHealth's PEG ratio is 0.01.
| PE Ratio | -0.45 |
| Forward PE | -0.53 |
| PS Ratio | 0.07 |
| Forward PS | 0 |
| PB Ratio | -0.05 |
| P/FCF Ratio | -0.49 |
| PEG Ratio | 0.01 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for NeueHealth.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of 0.
| Current Ratio | 0.61 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.03 |
| Debt / FCF | -0.02 |
| Interest Coverage | -5.46 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $949.96K |
| Profits Per Employee | $-136.59K |
| Employee Count | 986 |
| Asset Turnover | 1.72 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2.6M |
| Effective Tax Rate | -2.61% |
Stock Price Statistics
The stock price has increased by 9.97% in the last 52 weeks. The beta is 0.55, so NeueHealth's price volatility has been higher than the market average.
| Beta | 0.55 |
| 52-Week Price Change | 9.97% |
| 50-Day Moving Average | 6.7 |
| 200-Day Moving Average | 5.88 |
| Relative Strength Index (RSI) | 48.94 |
| Average Volume (20 Days) | 25.64K |
Income Statement
In the last 12 months, NeueHealth had revenue of 936.66M and earned -134.68M in profits. Earnings per share was -16.37.
| Revenue | 936.66M |
| Gross Profit | 194.52M |
| Operating Income | -102.06M |
| Net Income | -134.68M |
| EBITDA | -65.11M |
| EBIT | -80.76M |
| Earnings Per Share (EPS) | -16.37 |
Balance Sheet
The company has 83.3M in cash and 2M in debt, giving a net cash position of 81.3M.
| Cash & Cash Equivalents | 83.3M |
| Total Debt | 2M |
| Net Cash | 81.3M |
| Retained Earnings | -4.44B |
| Total Assets | 544.38M |
| Working Capital | -275.58M |
Cash Flow
In the last 12 months, operating cash flow was -123.22M and capital expenditures -2.33M, giving a free cash flow of -125.55M.
| Operating Cash Flow | -123.22M |
| Capital Expenditures | -2.33M |
| Free Cash Flow | -125.55M |
| FCF Per Share | -15.26 |
Margins
Gross margin is 20.77%, with operating and profit margins of -10.9% and -14.38%.
| Gross Margin | 20.77% |
| Operating Margin | -10.9% |
| Pretax Margin | -10.62% |
| Profit Margin | -14.38% |
| EBITDA Margin | -6.95% |
| EBIT Margin | -10.9% |
| FCF Margin | -13.4% |
Dividends & Yields
NEUE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for NEUE is $7, which is 9.4% higher than the current price. The consensus rating is "Hold".
| Price Target | $7 |
| Price Target Difference | 9.4% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 22, 2023. It was a backward split with a ratio of 1:80.
| Last Split Date | May 22, 2023 |
| Split Type | backward |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | -10.77 |
| Piotroski F-Score | 4 |